You are here

COLLABORATIONS PHARMACEUTICALS, INC.

Company Information
Address
5616 Hilltop Needmore Rd
Fuquay Varina, NC 27526-9278
United States


http://www.collaborationspharma.com/

Information

DUNS: 079704473

# of Employees: 10


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. MegaTrans- human transporter machine learning models

    Amount: $210,712.00

    Summary Being able to predict interactions with important human transporters would be of value to new drug design to avoid compounds that interact with them and cause undesirable side effectsOATP BSLC ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  2. MegaPredict for predicting natural product uses and their drug interactions

    Amount: $224,548.00

    Project Summary The objective of ‘MegaPredict’ is to enable scientists to generate predictions for a natural product (or any molecule) and identify targets for efficacy assessment as well as ident ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  3. MegaTox for analyzing and visualizing data across different screening systems

    Amount: $349,463.00

    Project Summary Computational toxicology aims to use rules, models and algorithms based on prior data for specific endpoints, to enable the prediction of whether a new molecule will possess similar li ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  4. Structure-guided optimization of an in vivo active small molecule antitubercular targeting KasA

    Amount: $224,998.00

    Project Summary The continued spread of drug resistant Mycobacterium tuberculosisMtbinfections has rendered tuberculosisTBa global health pandemic and pressed home the urgent need for new drugsCompoun ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  5. Enzyme Replacement Therapy For Infantile Onset Neuronal Ceroid Lipofuscinoses

    Amount: $411,523.00

    Executive summary SBIR awardRNSThe neuronal ceroid lipofuscinosesNCLsare lysosomal storage diseasesLSDswith a prevalence of approximatelyto nine per million populationtoperlive birthsThe infantile ons ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  6. Centralized assay datasets for modelling support of small drug discovery organizations

    Amount: $1,575,776.00

    Project Summary We have recently used computational models to identify the protease inhibitor indinavirused as an antiviral for HIVas a positive allosteric modulator at thenicotinic acetylcholine rece ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  7. Centralized assay datasets for modelling support of small drug discovery organizations

    Amount: $149,999.00

    Summary The objective of Assay Central is to compile a comprehensive collection of datasets for structure activity data for a broad variety of disease targets and absorption distribution metabolis ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  8. Optimization of small molecule triazine antituberculars for in vivo efficacy

    Amount: $149,388.00

    DESCRIPTION provided by applicant Tuberculosis TB is due to infection with the pathogen Mycobacterium tuberculosis Mtb This disease represents a global health pandemic as based on WHO statisti ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government